Tel: 020 7188 7188
Fax: 020 7188 4271
Dr Sarker graduated in medicine from the University of Liverpool in 1997, and subsequently trained in internal medicine and medical oncology. In 2003 he was appointed to a Cancer Research UK clinical research fellowship in the drug development unit of The Royal Marsden Hospital, and in Professor Paul Workman’s signal transduction and molecular pharmacology lab group at The Institute of Cancer Research, which led to the award of a PhD. He completed specialist training in medical oncology in 2009, and was subsequently appointed to his new post as clinical senior lecturer in medical oncology at King’s in 2010.
Dr Sarker's research focus is in the development of novel therapies for cancer, and together with Dr James Spicer, runs the early phase clinical trials unit based at Guy’s Hospital.
He has a particular interest in the development of signal transduction inhibitors, and the application of novel predictive and pharmacodynamic biomarkers, especially using molecular imaging. He is also actively involved in the management of hepato-pancreatic-biliary malignancies at Guy's and King's College Hospital liver unit, and has a specific interest in the development of new therapies and molecular imaging for these tumours.
- Cancer drug development
- Cancer imaging
- Biomarker development
- HPB cancers